Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ocular Therapeutix, Inc.(OCUL) | 6,070,000 | 6,653,138 | +583,138 | $27.07M | $60.54M | 13.19% | +$33.47M |
| Harrow, Inc.(HROW) | 3,820,000 | 3,920,600 | +100,600 | $42.78M | $51.87M | 11.30% | +$9.09M |
| TG Therapeutics, Inc.(TGTX) | 2,215,000 | 2,280,000 | +65,000 | $37.83M | $34.68M | 7.56% | -$3.15M |
| Keros Therapeutics, Inc.(KROS) | 357,500 | 367,500 | +10,000 | $14.21M | $24.33M | 5.30% | +$10.11M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 610,000 | 515,000 | -95,000 | $28.04M | $22.31M | 4.86% | -$5.73M |
| Catalyst Pharmaceuticals Inc | 1,257,200 | 1,004,355 | -252,845 | $21.44M | $16.01M | 3.49% | -$5.43M |
| Arvinas, Inc.(ARVN) | 263,700 | 330,000 | +66,300 | $10.85M | $13.62M | 2.97% | +$2.77M |
| Iovance Biotherapeutics, Inc.(IOVA) | 897,000 | 897,000 | 0 | $7.29M | $13.29M | 2.90% | +$6.00M |
| Jasper Therapeutics, Inc.(JSPR) | 0 | 435,573 | +435,573 | $0 | $12.79M | 2.79% | +$12.79M |
| Edgewise Therapeutics, Inc.(EWTX) | 699,000 | 665,000 | -34,000 | $7.65M | $12.13M | 2.64% | +$4.48M |
| Applied Therapeutics | 1,092,500 | 1,770,000 | +677,500 | $3.66M | $12.04M | 2.62% | +$8.38M |
| 4d Molecular Therapeutics Inc | 308,500 | 344,123 | +35,623 | $6.25M | $10.96M | 2.39% | +$4.71M |
| Codexis, Inc.(CDXS) | 3,045,525 | 3,120,000 | +74,475 | $9.29M | $10.89M | 2.37% | +$1.60M |
| Protara Therapeutics, Inc.(TARA) | 2,692,594 | 2,692,594 | 0 | $5.05M | $10.80M | 2.35% | +$5.75M |
| Acelyrin Inc | 4,146,138 | 1,580,000 | -2,566,138 | $30.93M | $10.66M | 2.32% | -$20.27M |
| Crinetics Pharmaceuticals Inc | 307,500 | 210,000 | -97,500 | $10.94M | $9.83M | 2.14% | -$1.11M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,529,887 | 2,445,781 | -84,106 | $11.08M | $9.17M | 2.00% | -$1.91M |
| Trevi Therapeutics, Inc.(TRVI) | 2,535,000 | 2,645,000 | +110,000 | $3.40M | $9.13M | 1.99% | +$5.73M |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 3,355,000 | +3,355,000 | $0 | $7.48M | 1.63% | +$7.48M |
| Newamsterdam Pharma Company ORDINARY SHARES | 265,388 | 315,388 | +50,000 | $2.96M | $7.46M | 1.63% | +$4.49M |
| Ventyx Biosciences Inc | 1,140,000 | 1,285,000 | +145,000 | $2.82M | $7.07M | 1.54% | +$4.25M |
| Intellia Therapeutics, Inc.(NTLA) | 99,000 | 255,000 | +156,000 | $3.02M | $7.02M | 1.53% | +$4.00M |
| Compass Therapeutics, Inc.(CMPX) | 0 | 3,170,000 | +3,170,000 | $0 | $6.28M | 1.37% | +$6.28M |
| Xoma Corp Del | 250,000 | 250,000 | 0 | $4.63M | $6.01M | 1.31% | +$1.39M |
| Liquidia Corporation(LQDA) | 445,000 | 395,000 | -50,000 | $5.35M | $5.83M | 1.27% | +$472.9K |
| Vaxcyte, Inc.(PCVX) | 90,000 | 85,000 | -5,000 | $5.65M | $5.81M | 1.27% | +$154.3K |
| Nyxoah S ASHS SHS | 344,800 | 320,000 | -24,800 | $1.60M | $4.32M | 0.94% | +$2.72M |
| Savara Inc.(SVRA) | 0 | 855,000 | +855,000 | $0 | $4.26M | 0.93% | +$4.26M |
| Syros Pharmaceuticals Inc | 359,370 | 787,545 | +428,175 | $2.80M | $4.21M | 0.92% | +$1.41M |
| UroGen Pharma Ltd.(URGN) | 320,000 | 270,000 | -50,000 | $4.80M | $4.05M | 0.88% | -$750.0K |
| Nurix Therapeutics, Inc.67080M103(NRIX) | 0 | 267,210 | +267,210 | $0 | $3.93M | 0.86% | +$3.93M |
| Revance Therapeutics Inc | 0 | 785,000 | +785,000 | $0 | $3.86M | 0.84% | +$3.86M |
| Relmada Therapeutics, Inc.(RLMD) | 877,000 | 759,000 | -118,000 | $3.63M | $3.53M | 0.77% | -$101.4K |
| Protagonist Therapeutics Inc | 112,700 | 112,700 | 0 | $2.58M | $3.26M | 0.71% | +$676.2K |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 0 | 0 | 0 | $2.92M | $3.21M | 0.70% | +$297.8K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 0 | 200,000 | +200,000 | $0 | $3.15M | 0.69% | +$3.15M |
| Allakos Inc | 0 | 2,435,000 | +2,435,000 | $0 | $3.07M | 0.67% | +$3.07M |
| Gossamer Bio, Inc.(GOSS) | 2,982,200 | 2,440,109 | -542,091 | $2.72M | $2.88M | 0.63% | +$158.1K |
| iBio, Inc.(IBIO) | 0 | 680,000 | +680,000 | $0 | $2.76M | 0.60% | +$2.76M |
| Verastem, Inc.(VSTM) | 211,400 | 211,400 | 0 | $1.72M | $2.49M | 0.54% | +$773.7K |
| Aligos Therapeutics Inc | 1,297,000 | 1,630,000 | +333,000 | $861.2K | $1.60M | 0.35% | +$736.2K |
| Context Therapeutics Inc.(CNTX) | 975,000 | 1,108,357 | +133,357 | $1.10M | $1.53M | 0.33% | +$427.8K |
| Precigen, Inc.(PGEN) | 1,012,500 | 947,500 | -65,000 | $1.36M | $1.37M | 0.30% | +$17.1K |
| Larimar Therapeutics, Inc.(LRMR) | 623,500 | 174,413 | -449,087 | $2.84M | $1.32M | 0.29% | -$1.51M |
| Fulcrum Therapeutics, Inc.(FULC) | 130,000 | 130,000 | 0 | $877.5K | $1.23M | 0.27% | +$349.7K |
| Morphosys AgADS | 145,000 | 65,000 | -80,000 | $1.44M | $1.18M | 0.26% | -$256.4K |
| Glaukos Corporation(GKOS) | 0 | 8,576 | +8,576 | $0 | $808.6K | 0.18% | +$808.6K |
| PMV Pharmaceuticals, Inc.(PMVP) | 0 | 471,481 | +471,481 | $0 | $802.1K | 0.17% | +$802.1K |
| Biodesix, Inc.(BDSX) | 496,500 | 534,657 | +38,157 | $3.61M | $764.6K | 0.17% | -$2.85M |
| Regulus Therapeutics Inc | 0 | 170,308 | +170,308 | $0 | $490.5K | 0.11% | +$490.5K |
| Design Therapeutics, Inc.(DSGN) | 0 | 113,038 | +113,038 | $0 | $455.5K | 0.10% | +$455.5K |
| REPARE THERAPEUTICS iNC | 0 | 67,561 | +67,561 | $0 | $318.2K | 0.07% | +$318.2K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 1,960,000 | 0 | -1,960,000 | $6.33M | $0 | — | -$6.33M |
| Biohaven Ltd.(BHVN) | 200,000 | 0 | -200,000 | $8.56M | $0 | — | -$8.56M |
| IDEAYA Biosciences, Inc.(IDYA) | 311,500 | 0 | -311,500 | $11.08M | $0 | — | -$11.08M |
| Jasper Therapeutics, Inc.(JSPR) | 3,985,340 | 0 | -3,985,340 | $3.14M | $0 | — | -$3.14M |
| Kalvista Pharmaceuticals Inc | 150,000 | 0 | -150,000 | $1.84M | $0 | — | -$1.84M |
| Kiniksa Pharmaceuticals LtdCL A | 37,500 | 0 | -37,500 | $640.2K | $0 | — | -$640.2K |
| Marinus Pharmaceuticals Inc | 563,500 | 0 | -563,500 | $6.13M | $0 | — | -$6.13M |
| Sutro Biopharma, Inc.(STRO) | 301,491 | 0 | -301,491 | $1.29M | $0 | — | -$1.29M |